The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.

被引:0
|
作者
La-Beck, N. M.
Wu, H.
Infante, J. R.
Jones, S. F.
Burris, H. A., III
Keedy, V. L.
Kodaira, H.
Ikeda, S.
Ramanathan, R. K.
Zamboni, W.
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Yakult Honsha, Tokyo, Japan
[8] Virginia G Piper Canc Ctr & TGen, Scottsdale, AZ USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13003
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Influence of gender on quinidine (Q) pharmacokinetics (PK).
    Benton, RE
    Flockhart, DA
    Sale, M
    Woosley, RL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PIII2 - PIII2
  • [42] Effects of race and gender on albuterol pharmacokinetics (PK).
    Mohamed, MHN
    Lima, JJ
    Eberle, LV
    Self, TH
    Johnson, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 164 - 164
  • [43] Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel
    Evangelos Briasoulis
    Vasilis Karavasilis
    Eleftheria Tzamakou
    Dimitra Rammou
    Kali Soulti
    Christina Piperidou
    Nicholas Pavlidis
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 452 - 457
  • [44] (1-4)-Thiodisaccharides as anticancer agents. Part 5. Evaluation of anticancer activity and investigation of mechanism of action
    Sarnik, Joanna
    Gajek, Arkadiusz
    Toma, Monika
    Pawelczyk, Jakub
    Rykowski, Sebastian
    Olejniczak, Agnieszka
    Sliwinski, Tomasz
    Bielski, Roman
    Witczak, Zbigniew J.
    Poplawski, Tomasz
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (04)
  • [45] Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel
    Briasoulis, E
    Karavasilis, V
    Tzamakou, E
    Rammou, D
    Soulti, K
    Piperidou, C
    Pavlidis, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (05) : 452 - 457
  • [46] Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
    Anders, Carey K.
    Adamo, Barbara
    Karginova, Olga
    Deal, Allison M.
    Rawal, Sumit
    Darr, David
    Schorzman, Allison
    Santos, Charlene
    Bash, Ryan
    Kafri, Tal
    Carey, Lisa
    Miller, C. Ryan
    Perou, Charles M.
    Sharpless, Norman
    Zamboni, William C.
    PLOS ONE, 2013, 8 (05):
  • [47] Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases
    Sugarbaker, Paul H.
    Stuart, O. Anthony
    EJSO, 2021, 47 (01): : 108 - 114
  • [48] Microwave-assisted synthesis of novel thiazolocarbazoles and evaluation as potential anticancer agents. Part III
    Testard, A
    Picot, L
    Fruitier-Arnaudin, I
    Piot, JM
    Chabane, H
    Domon, L
    Thiery, V
    Besson, T
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (06) : 467 - 473
  • [49] Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes
    Zhai, Bingtao
    Wu, Qibiao
    Wang, Wengang
    Zhang, Mingming
    Han, Xuemeng
    Li, Qiujie
    Chen, Peng
    Chen, Xiaying
    Huang, Xingxing
    Li, Guohua
    Zhang, Qin
    Zhang, Ruonan
    Xiang, Yu
    Liu, Shuiping
    Duan, Ting
    Lou, Jianshu
    Xie, Tian
    Sui, Xinbing
    CANCER BIOLOGY & MEDICINE, 2020, 17 (01) : 60 - +
  • [50] Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes
    Bingtao Zhai
    Qibiao Wu
    Wengang Wang
    Mingming Zhang
    Xuemeng Han
    Qiujie Li
    Peng Chen
    Xiaying Chen
    Xingxing Huang
    Guohua Li
    Qin Zhang
    Ruonan Zhang
    Yu Xiang
    Shuiping Liu
    Ting Duan
    Jianshu Lou
    Tian Xie
    Xinbing Sui
    Cancer Biology & Medicine , 2020, (01) : 60 - 75